Indo Borax Board Approves FY26 Audited Results & Recommends Rs. 40/Share Dividend
Indo Borax & Chemicals Limited announced audited standalone and consolidated financial results for FY26. The company recommended a final dividend of ₹10 and a special dividend of ₹30 per share, totaling ₹40 per share for FY26, subject to shareholder approval at the AGM. Internal and Cost Auditors were appointed/re-appointed for FY27.
The recommendation of a substantial dividend and the approval of annual financial results are material events that can significantly influence investor decisions and stock price.
The company reported positive financial results and recommended a significant dividend, which is generally viewed favorably by investors.
Indo Borax & Chemicals Limited announced the outcome of its Board Meeting held on Thursday, May 21, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. They also approved the statement of assets and liabilities as of March 31, 2026, and the cash flow statement for the financial year ended March 31, 2026.
The Board has recommended a final dividend of ₹10 per equity share and a special dividend of ₹30 per equity share for the financial year 2025-26. These dividends are subject to the approval of the shareholders at the upcoming 45th Annual General Meeting (AGM).
Furthermore, the company has appointed M/s. Shah Kapadia & Associates as Internal Auditors for FY 2026-27 and re-appointed M/s. V. B. Modi & Associates as Cost Auditors for FY 2026-27, subject to shareholder ratification of remuneration at the AGM. The Nomination and Remuneration Committee (NRC) of the Company has also been reconstituted.
The audited financial results, which received an unmodified audit opinion from the statutory auditors, are available on the company's website, www.indoborax.com, and stock exchange websites. The Board meeting commenced at 11:30 am IST and concluded at 02:10 pm IST.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.